SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMLN (DIABETES DRUGS)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Andrew H who wrote (588)8/21/1997 9:14:00 PM
From: David Bogdanoff   of 2173
 
AH;

IMHO, the drug results will be positive and the market response will be the same, probably occurring even before the announcement. Despite the managements poor PR (I suspect they thought the investing community would be happy with it), the results are positive enough and, importantly, J&J is behind it big time, so that we can reasonably expect an FDA approval and a marketed drug. A similar phenomenon has been happening with Corr Therapeutics (another MM pick): it dropped big time on an FDA disappointment, but now the stock has risen with more data coming in.

David
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News